Francesca M. Rossi

Aviano, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 62 publications

Sustainable Silk Fibroin Nanofibers Membranes with Natural Photothermal and Bioactive Components for Adhesive-Free Soft Tissue Repair.

Sustainable Silk Fibroin Nanofibers Membranes with Natural Photothermal and Bioactive Components for Adhesive-Free Soft Tissue Repair.

Journal: ACS applied bio materials

Published: January 23, 2026

IL-16 production is a mechanism of resistance to BTK inhibitors and R-CHOP in lymphomas.

IL-16 production is a mechanism of resistance to BTK inhibitors and R-CHOP in lymphomas.

Journal: bioRxiv : the preprint server for biology

Published: July 14, 2025

IL-16 production is a mechanism of resistance to BTK inhibitors and R-CHOP in lymphomas.

IL-16 production is a mechanism of resistance to BTK inhibitors and R-CHOP in lymphomas.

Journal: Blood

Published: May 14, 2025

IL-16 production is a mechanism of resistance to BTK inhibitors and R-CHOP in lymphomas.

IL-16 production is a mechanism of resistance to BTK inhibitors and R-CHOP in lymphomas.

Journal: Blood

Published: May 14, 2025

Measurement of Immunoglobulin Intraclonal diversification refines the clinical impact of IGHV mutational status in chronic lymphocytic leukemia.

Measurement of Immunoglobulin Intraclonal diversification refines the clinical impact of IGHV mutational status in chronic lymphocytic leukemia.

Journal: Leukemia

Published: February 13, 2025

Total Metabolic Tumor Volume Is a Strong Independent Prognostic Factor in Follicular Lymphomas: Results From a Sub-Study of the FOLL12 Trial.

Total Metabolic Tumor Volume Is a Strong Independent Prognostic Factor in Follicular Lymphomas: Results From a Sub-Study of the FOLL12 Trial.

Journal: American journal of hematology

Published: December 09, 2024

CD49d expression is included in a revised 4-factor model predicting outcome in patients with chronic lymphocytic leukemia treated with ibrutinib: A multicenter real-world experience.

CD49d expression is included in a revised 4-factor model predicting outcome in patients with chronic lymphocytic leukemia treated with ibrutinib: A multicenter real-world experience.

Journal: HemaSphere

Published: April 26, 2024

Low Cell Bioenergetic Metabolism Characterizes Chronic Lymphocytic Leukemia Patients with Unfavorable Genetic Factors and with a Better Response to BTK Inhibition.

Low Cell Bioenergetic Metabolism Characterizes Chronic Lymphocytic Leukemia Patients with Unfavorable Genetic Factors and with a Better Response to BTK Inhibition.

Journal: Current issues in molecular biology

Published: March 21, 2024

The VLA-4 integrin is constitutively active in circulating chronic lymphocytic leukemia cells via BCR autonomous signaling: a novel anchor-independent mechanism exploiting soluble blood-borne ligands.

The VLA-4 integrin is constitutively active in circulating chronic lymphocytic leukemia cells via BCR autonomous signaling: a novel anchor-independent mechanism exploiting soluble blood-borne ligands.

Journal: Leukemia

Published: March 04, 2024

The time to first treatment is an independent predictor of overall survival in chronic lymphocytic leukemia.

The time to first treatment is an independent predictor of overall survival in chronic lymphocytic leukemia.

Journal: American journal of hematology

Published: February 06, 2023

ERBB4-Mediated Signaling Is a Mediator of Resistance to PI3K and BTK Inhibitors in B-cell Lymphoid Neoplasms.

ERBB4-Mediated Signaling Is a Mediator of Resistance to PI3K and BTK Inhibitors in B-cell Lymphoid Neoplasms.

Journal: Molecular cancer therapeutics

Published: February 02, 2023

ERBB4-mediated signaling is a mediator of resistance to BTK and PI3K inhibitors in B cell lymphoid neoplasms.

ERBB4-mediated signaling is a mediator of resistance to BTK and PI3K inhibitors in B cell lymphoid neoplasms.

Journal: bioRxiv : the preprint server for biology

Published: January 30, 2023

Showing 1-12 of 62

Last Updated: 09/26/2026